Loading clinical trials...

Vibraimage Technology for Detecting Depression in Psychiatric Outpatients | Clinical Trials | Clareo Health

COMPLETED

Vibraimage Technology for Detecting Depression in Psychiatric Outpatients

Diagnostic Accuracy of Vibraimage Technology for Detecting Depression in a Psychiatric Outpatient Setting

NCT06793176•Peking University People's Hospital

Summary

Vibraimage technology captures high-frame-rate images of head-neck movements, converting them into vibraimages that display muscle vibration amplitude and frequency. Using algorithms and calculations, it derives an emotional index from these images. This non-contact, objective method analyzes psychological indicators through micro-movement detection. An algorithm has been developed to detect depression by calculating 12 emotional and 2 psychophysiological parameters. This diagnostic accuracy study aims to validate the technology's ability to diagnose depression in psychiatric outpatients.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Aged 18 to 70 years.
•No difficulties in reading or writing Chinese; fluent in Mandarin.
•Currently not taking psychotropic medications or on a stable dose for at least 6 weeks.
•Provided informed consent to participate in the study.

Exclusion Criteria

•Schizophrenia.
•Bipolar disorder.
•History of organic brain disease or significant head trauma.
•Presence of severe systemic medical conditions.
•Suicidal ideation or a score ≥3 on Item 3 ("Suicide") of the 17-item Hamilton Depression Rating Scale (HAMD-17).
•Substance dependence or abuse.
•Intellectual disability or dementia.
•Inability to complete video capture or cooperate due to uncontrollable factors (e.g., hyperactivity, Parkinson's disease, or other conditions that prevent remaining still)

Locations (1)

Beijing HuiLongGuan Hospital

Beijing, China

Key Dates

Start Date

January 26, 2025

Primary Completion Date

March 1, 2025

Completion Date

March 1, 2025

Last Updated

March 5, 2025

Enrollment

601

ACTUAL participants

Conditions

Depression

Interventions

Video capture

DIAGNOSTIC_TEST

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Vibraimage Technology for Detecting Depression in Psychiatric Outpatients

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures